Focused Ultrasound May Benefit Patients with Epilepsy
|
By HospiMedica International staff writers Posted on 17 Nov 2021 |
|
Image: Focused ultrasound being delivered using neuronavigation and EEG monitoring (Photo courtesy of Hsiang-Yu Yu/ VGHTPE)
A new study suggests that focused ultrasound (FUS) of the brain may benefit patients with drug-resistant epilepsy (DRE).
Researchers at National Yang Ming Chiao Tung University (NYCU; Taipei, Taiwan), Taipei Veterans General Hospital (Taiwan), and other institutions conducted a study in six DRE patients who were scheduled to undergo stereo-electroencephalography (SEEG) for localization of the seizure onset zone (SOZ), providing a window of opportunity to investigate the neuromodulatory effects of FUS. Simultaneous SEEG recordings were obtained during sonication and for three days after treatment to monitor seizures, interictal epileptiform discharges, and adverse events.
The results revealed a decrease in seizure frequency in two patients within the three-day follow-up, with significant changes in spectral power of SEEG noted at the targeted electrodes during FUS; one patient showed an increase in the frequency of subclinical seizures. Magnetic resonance imaging (MRI) revealed neither lesion nor brain edema. One patient reported subjective scalp heating during FUS, and one patient developed transient naming and memory impairment that resolved within three weeks. The study was published on November 2, 2021, in Epilepsia.
“Neuromodulation is an alternative treatment for drug-resistant epilepsy. Compared with the present modalities used in neuromodulation for epilepsy, focused ultrasound can access deeper brain regions and focus on the main target of the epileptic network in a relatively less invasive approach,” said senior author Hsiang-Yu Yu, PhD, of VGHTPE and the NYCU Brain Research Center. “It gives new hope and sheds new light for patients with drug-resistant epilepsy.”
Focused ultrasound is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens in such a way that that ultrasound pressure is focused precisely on the location of the tissue to be treated, while the surrounding tissue retains as little damage as possible.
Related Links:
National Yang Ming Chiao Tung University
Taipei Veterans General Hospital
Researchers at National Yang Ming Chiao Tung University (NYCU; Taipei, Taiwan), Taipei Veterans General Hospital (Taiwan), and other institutions conducted a study in six DRE patients who were scheduled to undergo stereo-electroencephalography (SEEG) for localization of the seizure onset zone (SOZ), providing a window of opportunity to investigate the neuromodulatory effects of FUS. Simultaneous SEEG recordings were obtained during sonication and for three days after treatment to monitor seizures, interictal epileptiform discharges, and adverse events.
The results revealed a decrease in seizure frequency in two patients within the three-day follow-up, with significant changes in spectral power of SEEG noted at the targeted electrodes during FUS; one patient showed an increase in the frequency of subclinical seizures. Magnetic resonance imaging (MRI) revealed neither lesion nor brain edema. One patient reported subjective scalp heating during FUS, and one patient developed transient naming and memory impairment that resolved within three weeks. The study was published on November 2, 2021, in Epilepsia.
“Neuromodulation is an alternative treatment for drug-resistant epilepsy. Compared with the present modalities used in neuromodulation for epilepsy, focused ultrasound can access deeper brain regions and focus on the main target of the epileptic network in a relatively less invasive approach,” said senior author Hsiang-Yu Yu, PhD, of VGHTPE and the NYCU Brain Research Center. “It gives new hope and sheds new light for patients with drug-resistant epilepsy.”
Focused ultrasound is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens in such a way that that ultrasound pressure is focused precisely on the location of the tissue to be treated, while the surrounding tissue retains as little damage as possible.
Related Links:
National Yang Ming Chiao Tung University
Taipei Veterans General Hospital
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Electrically Operated Patient Lifter
SVL 205
New
Hemostatic Agent
HEMOBLAST Bellows
Latest Patient Care News
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
Channels
Critical Care
view channel
Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more
New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
Barrett’s esophagus is a condition in which the lining of the esophagus—normally composed of squamous epithelial cells—undergoes a transformation into cells resembling those found in the stomach or intestine.... Read more
Surgical Techniques
view channel
Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
Aneurysms, especially when located in the brain, can be life-threatening if not treated effectively. Intracranial aneurysms, caused by the dilation of blood vessels due to weaknesses in the vessel wall,... Read more
New Surgical Technique Safely Removes Giant Nerve Tumors
Giant plexiform neurofibromas (PNF) are benign tumors commonly associated with neurofibromatosis Type 1 (NF1), a genetic disorder affecting approximately 1 in 3,000 live births. These tumors, which occur... Read more
Health IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
